# Take Two Interactive Software Inc: financial statements, quarterly TTWO · Nasdaq · CIK 946581 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/ttwo.md) · [Financials](/companies/ttwo/financials.md) · [Filings](/companies/ttwo/filings.md) · [Insiders](/companies/ttwo/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttwo/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,299](/filings/0001628280-24-045867.md) | [1,366](/filings/0001628280-25-004308.md) | [1,399 d](/filings/0001628280-26-037434.md) | [1,338](/filings/0001628280-25-038963.md) | [1,353](/filings/0001628280-25-050326.md) | [1,360](/filings/0001628280-26-005119.md) | [1,583 d](/filings/0001628280-26-037434.md) | [1,504](/filings/0001628280-26-054870.md) | [1,774](/filings/0001628280-25-050326.md) | [1,699](/filings/0001628280-26-005119.md) | [1,680 d](/filings/0001628280-26-037434.md) | [1,534](/filings/0001628280-26-054870.md) | | Cost of revenue | $m | [884](/filings/0001628280-24-045867.md) | [688](/filings/0001628280-25-004308.md) | [930 d](/filings/0001628280-26-037434.md) | [567](/filings/0001628280-25-038963.md) | [625](/filings/0001628280-25-050326.md) | [600](/filings/0001628280-26-005119.md) | [779 d](/filings/0001628280-26-037434.md) | [559](/filings/0001628280-26-054870.md) | [793](/filings/0001628280-25-050326.md) | [754](/filings/0001628280-26-005119.md) | [741 d](/filings/0001628280-26-037434.md) | [651](/filings/0001628280-26-054870.md) | | Gross profit | $m | [415](/filings/0001628280-24-045867.md) | [678](/filings/0001628280-25-004308.md) | [469 d](/filings/0001628280-26-037434.md) | [771](/filings/0001628280-25-038963.md) | [728](/filings/0001628280-25-050326.md) | [760](/filings/0001628280-26-005119.md) | [803 d](/filings/0001628280-26-037434.md) | [945](/filings/0001628280-26-054870.md) | [981](/filings/0001628280-25-050326.md) | [946](/filings/0001628280-26-005119.md) | [939 d](/filings/0001628280-26-037434.md) | [883](/filings/0001628280-26-054870.md) | | Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | [(544)](/filings/0001628280-24-045867.md) | [(130)](/filings/0001628280-25-004308.md) | [(2,713) d](/filings/0001628280-26-037434.md) | [(185)](/filings/0001628280-25-038963.md) | [(297)](/filings/0001628280-25-050326.md) | [(132)](/filings/0001628280-26-005119.md) | [(3,777) d](/filings/0001628280-26-037434.md) | [21.6](/filings/0001628280-26-054870.md) | [(98.0)](/filings/0001628280-25-050326.md) | [(38.7)](/filings/0001628280-26-005119.md) | [10.9 d](/filings/0001628280-26-037434.md) | [(35.5)](/filings/0001628280-26-054870.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [38.9](/filings/0001628280-26-054870.md) | not reported | not reported | not reported | [30.4](/filings/0001628280-26-054870.md) | | Income tax | $m | [(33.4)](/filings/0001628280-24-045867.md) | [(60.7)](/filings/0001628280-25-004308.md) | [158 d](/filings/0001628280-26-037434.md) | [49.8](/filings/0001628280-25-038963.md) | [41.2](/filings/0001628280-25-050326.md) | [(27.7)](/filings/0001628280-26-005119.md) | [(75.7) d](/filings/0001628280-26-037434.md) | [(1.9)](/filings/0001628280-26-054870.md) | [18.4](/filings/0001628280-25-050326.md) | [37.1](/filings/0001628280-26-005119.md) | [46.8 d](/filings/0001628280-26-037434.md) | [(15.2)](/filings/0001628280-26-054870.md) | | Net income | $m | [(544)](/filings/0001628280-24-045867.md) | [(91.6)](/filings/0001628280-25-004308.md) | [(2,903) d](/filings/0001628280-26-037434.md) | [(262)](/filings/0001628280-25-038963.md) | [(366)](/filings/0001628280-25-050326.md) | [(125)](/filings/0001628280-26-005119.md) | [(3,726) d](/filings/0001628280-26-037434.md) | [(11.9)](/filings/0001628280-26-054870.md) | [(134)](/filings/0001628280-25-050326.md) | [(92.9)](/filings/0001628280-26-005119.md) | [(59.5) d](/filings/0001628280-26-037434.md) | [(34.1)](/filings/0001628280-26-054870.md) | | Diluted EPS | $ per share | [(3.20)](/filings/0001628280-24-045867.md) | [(0.54)](/filings/0001628280-25-004308.md) | not reported | [(1.52)](/filings/0001628280-25-038963.md) | [(2.08)](/filings/0001628280-25-050326.md) | [(0.71)](/filings/0001628280-26-005119.md) | not reported | [(0.07)](/filings/0001628280-26-054870.md) | [(0.73)](/filings/0001628280-25-050326.md) | [(0.50)](/filings/0001628280-26-005119.md) | not reported | [(0.18)](/filings/0001628280-26-054870.md) | | Basic EPS | $ per share | [(3.20)](/filings/0001628280-24-045867.md) | [(0.54)](/filings/0001628280-25-004308.md) | not reported | [(1.52)](/filings/0001628280-25-038963.md) | [(2.08)](/filings/0001628280-25-050326.md) | [(0.71)](/filings/0001628280-26-005119.md) | not reported | [(0.07)](/filings/0001628280-26-054870.md) | [(0.73)](/filings/0001628280-25-050326.md) | [(0.50)](/filings/0001628280-26-005119.md) | not reported | [(0.18)](/filings/0001628280-26-054870.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: not reported - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [0.8](/filings/0001628280-23-037956.md) | [0.9](/filings/0001628280-24-003951.md) | [0.8](/filings/0001628280-25-026694.md) | [1.1](/filings/0001628280-24-036273.md) | [0.9](/filings/0001628280-24-045867.md) | [1.2](/filings/0001628280-25-004308.md) | [1.5](/filings/0001628280-26-037434.md) | [2.0](/filings/0001628280-25-038963.md) | [1.9](/filings/0001628280-25-050326.md) | [2.2](/filings/0001628280-26-005119.md) | [1.5](/filings/0001628280-26-054870.md) | [1.4](/filings/0001628280-26-054870.md) | | Current assets | $bn | [2.5](/filings/0001628280-23-037956.md) | [2.2](/filings/0001628280-24-003951.md) | [2.3](/filings/0001628280-25-026694.md) | [2.6](/filings/0001628280-24-036273.md) | [2.7](/filings/0001628280-24-045867.md) | [2.4](/filings/0001628280-25-004308.md) | [2.8](/filings/0001628280-26-037434.md) | [3.3](/filings/0001628280-25-038963.md) | [3.8](/filings/0001628280-25-050326.md) | [3.7](/filings/0001628280-26-005119.md) | [3.2](/filings/0001628280-26-054870.md) | [3.0](/filings/0001628280-26-054870.md) | | Total assets | $bn | [15.2](/filings/0001628280-23-037956.md) | [14.9](/filings/0001628280-24-003951.md) | [12.2](/filings/0001628280-25-026694.md) | [12.9](/filings/0001628280-24-036273.md) | [13.1](/filings/0001628280-24-045867.md) | [12.7](/filings/0001628280-25-004308.md) | [9.2](/filings/0001628280-26-037434.md) | [9.7](/filings/0001628280-25-038963.md) | [10.1](/filings/0001628280-25-050326.md) | [10.0](/filings/0001628280-26-005119.md) | [9.4](/filings/0001628280-26-054870.md) | [9.1](/filings/0001628280-26-054870.md) | | Current liabilities | $bn | [3.0](/filings/0001628280-23-037956.md) | [2.7](/filings/0001628280-24-003951.md) | [2.4](/filings/0001628280-25-026694.md) | [2.8](/filings/0001628280-24-036273.md) | [3.2](/filings/0001628280-24-045867.md) | [2.9](/filings/0001628280-25-004308.md) | [3.6](/filings/0001628280-26-037434.md) | [2.8](/filings/0001628280-25-038963.md) | [3.3](/filings/0001628280-25-050326.md) | [3.2](/filings/0001628280-26-005119.md) | [2.6](/filings/0001628280-26-054870.md) | [2.8](/filings/0001628280-26-054870.md) | | Total liabilities | $bn | [6.8](/filings/0001628280-23-037956.md) | [6.4](/filings/0001628280-24-003951.md) | [6.5](/filings/0001628280-25-026694.md) | [7.0](/filings/0001628280-24-036273.md) | [7.3](/filings/0001628280-24-045867.md) | [7.0](/filings/0001628280-25-004308.md) | [7.0](/filings/0001628280-26-037434.md) | [6.2](/filings/0001628280-25-038963.md) | [6.6](/filings/0001628280-25-050326.md) | [6.5](/filings/0001628280-26-005119.md) | [5.9](/filings/0001628280-26-054870.md) | [5.5](/filings/0001628280-26-054870.md) | | Long-term debt | $bn | [2.7](/filings/0001628280-23-037956.md) | [2.7](/filings/0001628280-24-003951.md) | [3.1](/filings/0001628280-25-026694.md) | [3.1](/filings/0001628280-24-036273.md) | [3.1](/filings/0001628280-24-045867.md) | [3.1](/filings/0001628280-25-004308.md) | [2.5](/filings/0001628280-26-037434.md) | [2.5](/filings/0001628280-25-038963.md) | [2.5](/filings/0001628280-25-050326.md) | [2.5](/filings/0001628280-26-005119.md) | [2.5](/filings/0001628280-26-054870.md) | [1.9](/filings/0001628280-26-054870.md) | | Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $bn | [0.4](/filings/0001628280-23-037956.md) | [0.4](/filings/0001628280-24-003951.md) | [0.0](/filings/0001628280-25-026694.md) | [0.6](/filings/0001628280-24-036273.md) | [0.6](/filings/0001628280-24-045867.md) | [0.6](/filings/0001628280-25-004308.md) | [1.1](/filings/0001628280-26-037434.md) | [0.5](/filings/0001628280-25-038963.md) | [0.5](/filings/0001628280-25-050326.md) | [0.6](/filings/0001628280-26-005119.md) | [0.0](/filings/0001628280-26-054870.md) | [0.6](/filings/0001628280-26-054870.md) | | Shareholders' equity | $bn | [8.4](/filings/0001628280-23-037956.md) | [8.5](/filings/0001628280-24-003951.md) | [5.7](/filings/0001628280-26-005119.md) | [6.0](/filings/0001628280-25-050326.md) | [5.8](/filings/0001628280-26-005119.md) | [5.7](/filings/0001628280-26-005119.md) | [2.1](/filings/0001628280-26-037434.md) | [3.5](/filings/0001628280-25-050326.md) | [3.4](/filings/0001628280-26-005119.md) | [3.5](/filings/0001628280-26-005119.md) | [3.5](/filings/0001628280-26-054870.md) | [3.6](/filings/0001628280-26-054870.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: not reported - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [64.8 d](/filings/0001628280-24-045867.md) | [(77.0) d](/filings/0001628280-25-004308.md) | [(8.9) d](/filings/0001628280-26-037434.md) | [(191)](/filings/0001628280-25-038963.md) | [(128) d](/filings/0001628280-25-050326.md) | [(4.8) d](/filings/0001628280-26-005119.md) | [279 d](/filings/0001628280-26-037434.md) | [(44.7)](/filings/0001628280-26-054870.md) | [128 d](/filings/0001628280-25-050326.md) | [305 d](/filings/0001628280-26-005119.md) | [235 d](/filings/0001628280-26-037434.md) | [(169)](/filings/0001628280-26-054870.md) | | Capital expenditure | $m | [28.4 d](/filings/0001628280-24-045867.md) | [35.6 d](/filings/0001628280-25-004308.md) | [46.2 d](/filings/0001628280-26-037434.md) | [35.1](/filings/0001628280-25-038963.md) | [36.8 d](/filings/0001628280-25-050326.md) | [43.4 d](/filings/0001628280-26-005119.md) | [54.1 d](/filings/0001628280-26-037434.md) | [25.1](/filings/0001628280-26-054870.md) | [31.9 d](/filings/0001628280-25-050326.md) | [69.0 d](/filings/0001628280-26-005119.md) | [36.8 d](/filings/0001628280-26-037434.md) | [25.0](/filings/0001628280-26-054870.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: not reported ## Shares | Line item | Unit | Q1 FY2020 (2019-06-30) | Q2 FY2020 (2019-09-30) | Q3 FY2020 (2019-12-31) | Q1 FY2021 (2020-06-30) | Q2 FY2021 (2020-09-30) | Q3 FY2021 (2020-12-31) | Q1 FY2022 (2021-06-30) | Q2 FY2022 (2021-09-30) | Q2 FY2022 (2021-12-31) | Q1 FY2023 (2022-06-30) | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [114](/filings/0001628280-20-011493.md) | [114](/filings/0001628280-20-015824.md) | [114](/filings/0001628280-21-001632.md) | [115](/filings/0001628280-21-015202.md) | [115](/filings/0001628280-21-021561.md) | [116](/filings/0001628280-22-001929.md) | [117](/filings/0001628280-22-021685.md) | [117](/filings/0001628280-22-028716.md) | [117](/filings/0001628280-23-002448.md) | [137](/filings/0001628280-22-021685.md) | [167](/filings/0001628280-22-028716.md) | [168](/filings/0001628280-23-002448.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 186,980,443 at 2026-07-27, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054870.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.